Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids

被引:359
作者
Lee, WJ
Shim, JY
Zhu, BT
机构
[1] Univ S Carolina, Coll Pharm, Dept Basic Pharmaceut Sci, Columbia, SC 29208 USA
[2] N Carolina Cent Univ, Biomed Biotechnol Res Inst, Durham, NC USA
关键词
D O I
10.1124/mol.104.008367
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the present investigation, we studied the modulating effects of several tea catechins and bioflavonoids on DNA methylation catalyzed by prokaryotic SssI DNA methyltransferase (DNMT) and human DNMT1. We found that each of the tea polyphenols [ catechin, epicatechin, and (-)-epigallocatechin-3-O-gallate (EGCG)] and bioflavonoids (quercetin, fisetin, and myricetin) inhibited SssI DNMT- and DNMT1-mediated DNA methylation in a concentration-dependent manner. The IC50 values for catechin, epicatechin, and various flavonoids ranged from 1.0 to 8.4 mu M, but EGCG was a more potent inhibitor, with IC50 values ranging from 0.21 to 0.47 mu M. When epicatechin was used as a model inhibitor, kinetic analyses showed that this catechol-containing dietary polyphenol inhibited enzymatic DNA methylation in vitro largely by increasing the formation of S-adenosyl-L-homocysteine (a potent noncompetitive inhibitor of DNMTs) during the catechol-O-methyltransferase-mediated O-methylation of this dietary catechol. In comparison, the strong inhibitory effect of EGCG on DNMT- mediated DNA methylation was independent of its own methylation and was largely due to its direct inhibition of the DNMTs. This inhibition is strongly enhanced by Mg2+. Computational modeling studies showed that the gallic acid moiety of EGCG plays a crucial role in its high-affinity, direct inhibitory interaction with the catalytic site of the human DNMT1, and its binding with the enzyme is stabilized by Mg2+. The modeling data on the precise molecular mode of EGCG's inhibitory interaction with human DNMT1 agrees perfectly with our experimental finding.
引用
收藏
页码:1018 / 1030
页数:13
相关论文
共 39 条
  • [1] Phase I trial of continuous infusion 5-aza-2′-deoxycytidine
    Aparicio, A
    Eads, CA
    Leong, LA
    Laird, PW
    Newman, EM
    Synold, TW
    Baker, SD
    Zhao, M
    Weber, JS
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 51 (03) : 231 - 239
  • [2] 2 DNA METHYLTRANSFERASES FROM MURINE ERYTHROLEUKEMIA-CELLS - PURIFICATION, SEQUENCE SPECIFICITY, AND MODE OF INTERACTION WITH DNA
    BESTOR, TH
    INGRAM, VM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (18): : 5559 - 5563
  • [3] Antineoplastic action of 5-aza-2′-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor β and estrogen receptor α genes in breast carcinoma cells
    Bovenzi, V
    Momparler, RL
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (01) : 71 - 76
  • [4] A METHOD TO IDENTIFY PROTEIN SEQUENCES THAT FOLD INTO A KNOWN 3-DIMENSIONAL STRUCTURE
    BOWIE, JU
    LUTHY, R
    EISENBERG, D
    [J]. SCIENCE, 1991, 253 (5016) : 164 - 170
  • [5] DNA hypomethylation leads to elevated mutation rates
    Chen, RZ
    Pettersson, U
    Beard, C
    Jackson-Grusby, L
    Jaenisch, R
    [J]. NATURE, 1998, 395 (6697) : 89 - 93
  • [6] STRUCTURE AND ENERGETICS OF LIGAND-BINDING TO PROTEINS - ESCHERICHIA-COLI DIHYDROFOLATE REDUCTASE TRIMETHOPRIM, A DRUG-RECEPTOR SYSTEM
    DAUBEROSGUTHORPE, P
    ROBERTS, VA
    OSGUTHORPE, DJ
    WOLFF, J
    GENEST, M
    HAGLER, AT
    [J]. PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1988, 4 (01): : 31 - 47
  • [7] ATOMIC LEVEL SIMULATIONS ON A MILLION PARTICLES - THE CELL MULTIPOLE METHOD FOR COULOMB AND LONDON NONBOND INTERACTIONS
    DING, HQ
    KARASAWA, N
    GODDARD, WA
    [J]. JOURNAL OF CHEMICAL PHYSICS, 1992, 97 (06) : 4309 - 4315
  • [8] Principles governing Mg, Ca, and Zn binding and selectivity in proteins
    Dudev, T
    Lim, C
    [J]. CHEMICAL REVIEWS, 2003, 103 (03) : 773 - 787
  • [9] Eads CA, 2002, CANCER RES, V62, P1296
  • [10] CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future
    Esteller, M
    [J]. ONCOGENE, 2002, 21 (35) : 5427 - 5440